Catalyst Biosciences

+$0.09 (+6.72%) Today
-$0.03 (-2.10%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBIO and other ETFs, options, and stocks.

About CBIO

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions.

CEO
Nassim Usman
Employees
45
Headquarters
South San Francisco, California
Founded
1997

CBIO Key Statistics

Market cap
45.01M
Price-Earnings ratio
—
Dividend yield
—
Average volume
32.23M
High today
$1.52
Low today
$1.20
Open price
$1.22
Volume
30.77M
52 Week high
$5.20
52 Week low
$0.3501

CBIO News

BenzingaMay 24

Short Volatility Alert: Catalyst Biosciences

On Modnay, shares of Catalyst Biosciences, Inc. CBIO experienced volatile short activity. After the activity, the stock price went up +234.21% to $1.27. The ove
MarketWatchMay 23

Catalyst Biosciences Shares Soar After Complement Portfolio Sale >CBIO - MarketWatch

By Colin Kellaher Shares of Catalyst Biosciences Inc. more than doubled in early trading Monday after the biopharmaceutical company said it sold its portfolio

CBIO Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure